Patentee Secures Reversal of JMOL on Written Description and Enablement for Method of Treatment by Administering Genus of Antibodies at Federal Circuit

Today the Federal Circuit reversed a district court’s JMOL and held that claims to a method of treating headaches using a genus of antagonistic anti-CGRP antibodies satisfied both the written description and enablement requirements. In particular, the court held that the prior art evidence demonstrates the genus was well known, methods of making the antibodies were routine and...... By: Akin Gump Strauss Hauer & Feld LLP